SREBF1 and cancer: Furthermore, mTORC1 was found to promote SREBP1 activity by preventing the nuclear entry of LIPIN1, the negative regulator of SREBP1, while mTORC2 promoted the expression of AKT, SREBP1’s downstream effector (79, 80), while preventing SREBP1 degradation in cancer cells (81).